Cas No.：441045-17-6
Status：Established(US DMF,ASMF)
Eribulin mesylate is a microtubule targeting agent that is used for the research of metastatic breast cancer. Eribulin mesylate inhibits the proliferation of cancer cells by binding microtubule proteins and microtubules.
